{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:30:18Z","timestamp":1769243418632,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13550-016-0230-7","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T10:30:40Z","timestamp":1476786640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2081-3020","authenticated-orcid":false,"given":"Kayako","family":"Isohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eku","family":"Shimosegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadahiro","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasukazu","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genki","family":"Horitsugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hatazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"230_CR1","first-page":"1061","volume":"50","author":"RF Barth","year":"1990","unstructured":"Barth RF, Soloway AH, Fairchild RG. Boron neutron capture therapy of cancer. Cancer Res. 1990;50:1061\u201370.","journal-title":"Cancer Res"},{"key":"230_CR2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.apradiso.2004.05.059","volume":"61","author":"I Kato","year":"2004","unstructured":"Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot. 2004;61:1069\u201373.","journal-title":"Appl Radiat Isot"},{"key":"230_CR3","doi-asserted-by":"publisher","unstructured":"Miyatake S, Kawabata S, Hiramatsu R, Furuse M, Kuroiwa T, Suzuki M. Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases. Radiat Oncol. 2014. doi: 10.1186\/1748-717X-9-6 .","DOI":"10.1186\/1748-717X-9-6"},{"key":"230_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jrr\/rrt098","volume":"55","author":"M Suzuki","year":"2014","unstructured":"Suzuki M, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M, et al. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J Radiat Res. 2014;55:146\u201353.","journal-title":"J Radiat Res"},{"key":"230_CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(89)90567-9","volume":"2","author":"Y Mishima","year":"1989","unstructured":"Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, et al. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet. 1989;2:388\u20139.","journal-title":"Lancet"},{"key":"230_CR6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0360-3016(94)90479-0","volume":"28","author":"H Hatanaka","year":"1994","unstructured":"Hatanaka H, Nakagawa Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys. 1994;28:1061\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"230_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0883-2889(91)90133-L","volume":"42","author":"K Ishiwata","year":"1991","unstructured":"Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y. Synthesis and radiation dosimetry of 4-borono-2-[18F] fluoro-D, L-phenylalanine: a target compound for PET and boron neutron capture therapy. Int J Rad Appl Instrum A. 1991;42:325\u20138.","journal-title":"Int J Rad Appl Instrum A"},{"key":"230_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.nucmedbio.2013.02.010","volume":"40","author":"M Yoshimoto","year":"2013","unstructured":"Yoshimoto M, Kurihara H, Honda N, Kawai K, Ohe K, Fujii H, et al. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18) F-fluoro-phenylalanine uptake in human glioblastoma cells. Nucl Med Biol. 2013;40:625\u20139.","journal-title":"Nucl Med Biol"},{"key":"230_CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13550-014-0070-2","volume":"4","author":"K Hanaoka","year":"2014","unstructured":"Hanaoka K, Watabe T, Naka S, Kanai Y, Ikeda H, Horitsugi G, et al. FBPA PET in boron neutron capture therapy for cancer: prediction of (10) B concentration in the tumor and normal tissue in a rat xenograft model. EJNMMI Res. 2014;4:70.","journal-title":"EJNMMI Res"},{"key":"230_CR10","first-page":"1833","volume":"4","author":"Y Imahori","year":"1998","unstructured":"Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res. 1998;4:1833\u201341.","journal-title":"Clin Cancer Res"},{"key":"230_CR11","first-page":"325","volume":"39","author":"Y Imahori","year":"1998","unstructured":"Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R, et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med. 1998;39:325\u201333.","journal-title":"J Nucl Med"},{"key":"230_CR12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hed.20418","volume":"28","author":"T Aihara","year":"2006","unstructured":"Aihara T, Hiratsuka J, Morita N, Uno M, Sakurai Y, Maruhashi A, et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. Head Neck. 2006;28:850\u20135.","journal-title":"Head Neck"},{"key":"230_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3892\/ol.2011.265","volume":"2","author":"Y Ariyoshi","year":"2011","unstructured":"Ariyoshi Y, Shimahara M, Kimura Y, Ito Y, Shimahara T, Miyatake SI, et al. Fluorine-18-labeled boronophenylalanine positron emission tomography for oral cancers: Qualitative and quantitative analyses of malignant tumors and normal structures in oral and maxillofacial regions. Oncol Lett. 2011;2:423\u20137.","journal-title":"Oncol Lett"},{"key":"230_CR14","first-page":"1762","volume":"38","author":"GW Kabalka","year":"1997","unstructured":"Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, et al. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. J Nucl Med. 1997;38:1762\u20137.","journal-title":"J Nucl Med"},{"key":"230_CR15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3171\/jns.2005.103.6.1000","volume":"103","author":"S Miyatake","year":"2005","unstructured":"Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, et al. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. J Neurosurg. 2005;103:1000\u20139.","journal-title":"J Neurosurg"},{"key":"230_CR16","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.apradiso.2009.03.103","volume":"67","author":"I Kato","year":"2009","unstructured":"Kato I, Fujita Y, Maruhashi A, Kumada H, Ohmae M, Kirihata M, et al. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl Radiat Isot. 2009;67:S37\u201342.","journal-title":"Appl Radiat Isot"},{"key":"230_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0360-3016(96)00241-6","volume":"36","author":"GE Laramore","year":"1996","unstructured":"Laramore GE, Spence AM. Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note. Int J Radiat Oncol Biol Phys. 1996;36:241\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"230_CR18","first-page":"2657","volume":"32","author":"YC Lin","year":"2012","unstructured":"Lin YC, Hwang JJ, Wang SJ, Yang BH, Chang CW, Hsiao MC, et al. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. Anticancer Res. 2012;32:2657\u201364.","journal-title":"Anticancer Res"},{"key":"230_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12149-013-0685-9","volume":"27","author":"M Sakata","year":"2013","unstructured":"Sakata M, Oda K, Toyohara J, Ishii K, Nariai T, Ishiwata K. Direct comparison of radiation dosimetry of six PET tracers using human whole-body imaging and murine biodistribution studies. Ann Nucl Med. 2013;27:285\u201396.","journal-title":"Ann Nucl Med"},{"key":"230_CR20","first-page":"1232","volume":"36","author":"H Ito","year":"1995","unstructured":"Ito H, Hatazawa J, Murakami M, Miura S, Iida H, Bloomfield PM, et al. Aging effect on neutral amino acid transport at the blood-brain barrier measured with L-[2-18F]-fluorophenylalanine and PET. J Nucl Med. 1995;36:1232\u20137.","journal-title":"J Nucl Med"},{"key":"230_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2191-219X-3-27","volume":"3","author":"K Isohashi","year":"2013","unstructured":"Isohashi K, Shimosegawa E, Kato H, Kanai Y, Naka S, Fujino K, et al. Optimization of [11C] methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV. EJNMMI Res. 2013;3:27.","journal-title":"EJNMMI Res"},{"key":"230_CR22","first-page":"699","volume":"32","author":"AA Mejia","year":"1991","unstructured":"Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699\u2013706.","journal-title":"J Nucl Med"},{"key":"230_CR23","first-page":"945","volume":"47","author":"LF De Geus-Oei","year":"2006","unstructured":"De Geus-Oei LF, Visser EP, Krabbe PF, Van Hoorn BA, Koenders EB, Willemsen AT, et al. Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies. J Nucl Med. 2006;47:945\u20139.","journal-title":"J Nucl Med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-016-0230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-016-0230-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-016-0230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T14:54:03Z","timestamp":1568472843000},"score":1,"resource":{"primary":{"URL":"http:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-016-0230-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1186\/s13550-016-0230-7","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]},"article-number":"75"}}